Hippocratic AI, a healthcare-focused startup, has raised an impressive $141 million in Series B funding at a valuation of $1.64 billion.
Kleiner Perkins led the investment, and it comes just months after the company secured $53 million from General Catalyst and Andreessen Horowitz and $17 million from Nvidia.
Founded less than two years ago, the startup is gaining significant traction for its innovative approach to addressing the shortage of healthcare professionals by focusing on non-diagnostic, patient-facing tasks.
Unlike most generative AI tools in healthcare that aim to reduce administrative workloads, Hippocratic AI develops solutions for tasks like remote patient monitoring, pre-operative procedures, and appointment preparation.
In 2024, the company has signed agreements with 23 health systems and insurers, a testament to the growing demand for its technology.
With the new funding, Hippocratic AI plans to scale its product offerings to more markets and expand internationally, further solidifying its position as a leader in healthcare AI innovation.
By tackling operational inefficiencies and workforce shortages, the startup aims to improve patient care and streamline processes across healthcare systems.
This funding round highlights the confidence investors have in the company’s mission to revolutionize patient interactions through cutting-edge AI solutions.
